definiens: shall mean consideration received by Company, its Affiliates and Sublicenseesfrom the sale of Licensed Products in the first arm ’s length transaction, less deductions appropriate under US GAAP(to the extent not already reflected in the cash received ) including, without limitation, administrative warehouse andservice fees paid by Company for third party commercial wholesalers and distributors, payments that are returned byCompany pursuant to applicable law, trade discounts or rebates allowed, refunds, returns and recalls, and sales, use, VAT, tariff, import / export duties, or other excise taxes that to be collected by Company and paid to governmentalauthorities or are invoiced to purchaser and/or paid and remitted by Company to third parties in connection with sale ofsuch Licensed Product . Net Sales Revenues of a Licensed Product with more than one therapeutically activecomponent ( ) sold by Company, its Sublicensees or Affiliates shall be calculated by multiplyingthe Net Sales Revenue of the Combination Product by the fraction A / A+B, where A is the number of all therapeuticallyactive components covered by the Licensed IP hereunder in the Combination Product, and B is the number of allother therapeutically active components in the Combination Product which are not covered by the Licensed IPhereunder . If Licensed Product is given away as part of a kit, or it is not sold but accompanies a product that is sold, then the sale price for the Licensed Product shall be deemed to be the proportional amount of the sale price based ona comparison at the fair market value of each component of the kit or of all products included in the sale . Anynoncash consideration received in consideration for the sale of a Licensed Product will be reasonably valued byCompany at fair market value